PlainPharmaWatch

CMS Open Payments · Program Year 2024

R-Pharm US LLC

R-Pharm US LLC reported $588.45 across General Payments, Research, and Ownership to 7 physicians and teaching hospitals across 7 transactions.

See the rankings → How this is sourced
$588.45
All-tracks total
7
Transactions
7
Recipients
#1874
of 1,925 companies

R-Pharm US LLC reported $588.45 across all CMS Open Payments tracks (General + Research + Ownership) to 7 physicians and teaching hospitals in Program Year 2024 - ranking #1874 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $588.45, averaging $84.06 per recipient.

Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.

Compiled from official public sources by the publisher.

CMS Sunshine Act warrant

Manufacturer r-pharm-us-llc R-Pharm US LLC

$588.45 · #1874/1,925 · 0.0% industry · PY2024

  • TOT $588.45
  • RANK #1874
  • SHARE 0.0%
  • TXN 7
  • RCP 7
  • CAT 1
  • GEN $588.45
  • TOP1 25.8%
  • PY 2024

Volume peers

Nearest volume peer: Vantage Technology LLC ($593.80)

Cook Biotech Incorporated$609.12Pixee Medical Inc.$601.00LumiraDx, Inc.$600.00Vantage Technology LLC$593.80R-Pharm US LLC (this)$588.45
All-tracks payment totals near R-Pharm US LLC (CMS Open Payments PY2024)

R-Pharm US LLC sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →

What the Data Shows for R-Pharm US LLC

Averaging $84.06 per transaction and $84.06 per recipient, R-Pharm US LLC's Program Year 2024 total comes to $588.45 across 7 transactions and 7 physicians and teaching hospitals. In the CMS Open Payments database that is good for rank #1874 of 1,925 companies, a comparatively small 0.0% slice of all industry payments reported nationwide for the year.

"Food and Beverage" leads the 1-category general-payment breakdown below at $588.45 (100.0% of General Payments, 7 transactions) - see our methodology for how research and ownership payments are reported separately.

General Payment Breakdown by Type

Across 1 types of general payments, R-Pharm US LLC's largest category was "Food and Beverage" at $588.45 - 100.0% of General Payments.

How R-Pharm US LLC divides its payments

General-payment categories, ordered by reported total

1. Food and Beverage$588.45
Payment Type Amount Transactions
Food and Beverage $588.45 7

Recipient Concentration in General Payments

The five largest recipient relationships account for $545.49 (92.7%) of $588.45 in this company's General Payments records across 7 recipients.

General Payments scope note

Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.

Largest General-Payment relationships for R-Pharm US LLC

The five named recipients with the highest reported General Payments from this company

Pedro Gil Solivan Ortiz$151.60Alessandro Santin$137.37Alexander Olawaiye$113.52Nuhad Ibrahim$83.52Mark Shahin$59.48
  1. 1

    Pedro Gil Solivan Ortiz

    $151.60 across 1 reported transactions

  2. 2

    Alessandro Santin

    $137.37 across 1 reported transactions

  3. 3

    Alexander Olawaiye

    $113.52 across 1 reported transactions

  4. 4

    Nuhad Ibrahim

    $83.52 across 1 reported transactions

  5. 5

    Mark Shahin

    $59.48 across 1 reported transactions

Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.

Similarly Concentrated Companies

Companies whose General Payments are spread across recipients about as (un)evenly as R-Pharm US LLC's, measured by the same HHI concentration index above, not by payment size.

What HHI 2,500 means here

2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about R-Pharm US LLC.

G21 Srl

HHI 1918

Dmg America LLC

HHI 1902

United Imaging Healthcare North America, Inc.

HHI 1892

ulrich medical USA, Inc.

HHI 1891

Companies with Similar Payment Volumes

Open a profile or compare a similar company's CMS-reported payment pattern with R-Pharm US LLC.

Showing 6 of 1,924 companies with CMS-reported payment data.

Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. Total industry payments: $13.9B across 1,925 companies.

Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch
Disclaimer

This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

View saved (companies)
Download R-Pharm US LLC's data (CSV)
Embed this widget

Copy this snippet to embed a live-linked card on your own site.

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.